Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study

被引:48
作者
Brazier, L
Tiret, L
Luc, G
Arveiler, D
Ruidavets, JB
Evans, A
Chapman, J
Cambien, F
Thillet, J
机构
[1] Hop Pitie, INSERM, U321, Unite Lipoprot & Atherogenese, F-75651 Paris 13, France
[2] Hop Broussais, INSERM, U258, Unite Epidemiol Cardiovasc, F-75674 Paris 15, France
[3] INSERM, F-75005 Paris, France
[4] MONICA Project, Lille, France
[5] MONICA Project, Toulouse, France
[6] MONICA Project, Belfast, Antrim, North Ireland
[7] MONICA Project, Strasbourg, France
关键词
case-control study; gene polymorphism; apolipoprotein(a); lipoprotein(a); isoform; coronary heart disease;
D O I
10.1016/S0021-9150(98)00333-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lp(a) concentrations are largely determined by apo(a) isoform size, but several studies have shown that apo(a) isoforms could not entirely explain the increase of Lp(a) levels observed in patients with coronary heart disease (CHD). Since up to 90% of the variance in Lp(a) levels has been suggested to be attributable to the apo(a) locus, the hypothesis that polymorphisms of the apo(a) gene other than size could contribute to the increase of Lp(a) levels in CHD patients must be considered. This hypothesis was tested in the ECTIM Study comparing 594 patients with myocardial infarction and 682 control subjects in Northern Ireland and France. In addition to apo(a) phenotyping, five previously described polymorphisms of the apo(a) gene were genotyped: a (TTTTA)(n) repeat at position -1400 from the ATG, a G/A at -914, a C/T at -49, a G/A at -21 and a Met/Thr affecting amino acid 4168. As reported earlier [Parra HJ, Evans AE, Cambou JP, Amouyel P, Bingham A, McMaster D, Schaffer P, Douste-Blazy P, Luc G, Richard JL, Ducimetiere P, Fruchart JC, Cambien F. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM study. Arterioscler Thromb 1992;12:701-707], mean Lp(a) levels were higher in cases than in controls (20.7 vs 14.6 mg/dl in Belfast, 17.2 vs 8.9 mg/dl in France, P < 0.001 for case-control and population differences). In the present study, mean apo(a) isoform size differed significantly between cases and controls (25.7 vs 26.6 kr in Belfast, 25.9 vs 27.4 kr in France, P < 0.001 for case-control and P = 0.13 for population difference). After adjustment for apo(a) isoforms, Lp(a) levels remained significantly higher in cases than in controls (difference, 4.6 mg/dl; P < 0.001). Genotype and allele frequencies did not differ significantly between cases and controls for any bf the five polymorphisms studied. The five polymorphisms were in strong linkage disequilibrium and had a combined heterozygosity of 0.83. In multivariate regression analysis adjusted for apo(a) isoforms, only the (TTTTA), polymorphism was significantly associated with Lp(a) levels; it explained 4.5% of Lp(a) variability in cases and 3.1% in controls. The Lp(a) case/control difference was not reduced after taking into account the (TTTTA)(n) effect. We conclude that the increase of Lp(a) levels observed in MI cases, and which was not directly attributable to apo(a) size variation, was not related to the five polymorphisms of the apo(a) gene considered. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:323 / 333
页数:11
相关论文
共 60 条
  • [1] RELATION OF SERUM HOMOCYSTEINE AND LIPOPROTEIN(A) CONCENTRATIONS TO ATHEROSCLEROTIC DISEASE IN A PROSPECTIVE FINNISH POPULATION-BASED STUDY
    ALFTHAN, G
    PEKKANEN, J
    JAUHIAINEN, M
    PITKANIEMI, J
    KARVONEN, M
    TUOMILEHTO, J
    SALONEN, JT
    EHNHOLM, C
    [J]. ATHEROSCLEROSIS, 1994, 106 (01) : 9 - 19
  • [2] Apolipoprotein(a) size and pentanucleotide repeat polymorphisms are associated with the degree of atherosclerosis in coronary heart disease
    Amemiya, H
    Arinami, T
    Kikuchi, S
    YamakawaKobayashi, K
    Li, L
    Fujiwara, H
    Hiroe, M
    Marumo, F
    Hamaguchi, H
    [J]. ATHEROSCLEROSIS, 1996, 123 (1-2) : 181 - 191
  • [3] THE ASSOCIATION BETWEEN SERUM LP(A) CONCENTRATIONS AND ANGIOGRAPHICALLY ASSESSED CORONARY ATHEROSCLEROSIS - DEPENDENCE ON SERUM LDL LEVELS
    ARMSTRONG, VW
    CREMER, P
    EBERLE, E
    MANKE, A
    SCHULZE, F
    WIELAND, H
    KREUZER, H
    SEIDEL, D
    [J]. ATHEROSCLEROSIS, 1986, 62 (03) : 249 - 257
  • [4] Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men
    Assmann, G
    Schulte, H
    vonEckardstein, A
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (14) : 1179 - 1184
  • [5] AUSTIN MA, 1992, AM J HUM GENET, V51, P829
  • [6] GENETICS OF THE QUANTITATIVE LP(A) LIPOPROTEIN TRAIT .3. CONTRIBUTION OF LP(A) GLYCOPROTEIN PHENOTYPES TO NORMAL LIPID VARIATION
    BOERWINKLE, E
    MENZEL, HJ
    KRAFT, HG
    UTERMANN, G
    [J]. HUMAN GENETICS, 1989, 82 (01) : 73 - 78
  • [7] APOLIPOPROTEIN(A) GENE ACCOUNTS FOR GREATER THAN 90-PERCENT OF THE VARIATION IN PLASMA LIPOPROTEIN(A) CONCENTRATIONS
    BOERWINKLE, E
    LEFFERT, CC
    LIN, JP
    LACKNER, C
    CHIESA, G
    HOBBS, HH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) : 52 - 60
  • [8] BOOSMSMA DI, 1993, ATHEROSCLEROSIS, V99, P23
  • [9] BOPP S, 1995, J LIPID RES, V36, P1721
  • [10] Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger - A prospective study
    Bostom, AG
    Cupples, LA
    Jenner, JL
    Ordovas, JM
    Seman, LJ
    Wilson, PWF
    Schaefer, EJ
    Castelli, WP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (07): : 544 - 548